Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 909409-91-2 | MDL No. : | MFCD08458967 |
Formula : | C10H20N2O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | XCVMVRBLFPBDIN-MRVPVSSYSA-N |
M.W : | 184.28 | Pubchem ID : | 24728865 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.9 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 61.54 |
TPSA : | 32.34 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.79 cm/s |
Log Po/w (iLOGP) : | 2.37 |
Log Po/w (XLOGP3) : | 0.9 |
Log Po/w (WLOGP) : | 0.09 |
Log Po/w (MLOGP) : | 0.9 |
Log Po/w (SILICOS-IT) : | 1.05 |
Consensus Log Po/w : | 1.06 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.42 |
Solubility : | 7.05 mg/ml ; 0.0382 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.16 |
Solubility : | 12.6 mg/ml ; 0.0685 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.69 |
Solubility : | 3.74 mg/ml ; 0.0203 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.95 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
[ 59878-57-8 ]
1-(Cyclopropylcarbonyl)piperazine
Similarity: 0.83
[ 1638137-85-5 ]
(S)-1-(3-Methylpiperazin-1-yl)ethanone hydrochloride
Similarity: 0.82
[ 1956325-48-6 ]
(3-Aminoazetidin-1-yl)(cyclopropyl)methanone hydrochloride
Similarity: 0.79
[ 27561-62-2 ]
Cyclohexyl(piperazin-1-yl)methanone
Similarity: 0.79
[ 1373232-29-1 ]
(R)-1,3-Dimethylpiperazin-2-one hydrochloride
Similarity: 0.78
[ 1956325-48-6 ]
(3-Aminoazetidin-1-yl)(cyclopropyl)methanone hydrochloride
Similarity: 0.79
[ 27561-62-2 ]
Cyclohexyl(piperazin-1-yl)methanone
Similarity: 0.79
[ 1373232-29-1 ]
(R)-1,3-Dimethylpiperazin-2-one hydrochloride
Similarity: 0.78
[ 344779-07-3 ]
4-(2-(Dimethylamino)ethyl)-1,4-diazepan-5-one
Similarity: 0.76
[ 59878-57-8 ]
1-(Cyclopropylcarbonyl)piperazine
Similarity: 0.83
[ 1638137-85-5 ]
(S)-1-(3-Methylpiperazin-1-yl)ethanone hydrochloride
Similarity: 0.82
[ 27561-62-2 ]
Cyclohexyl(piperazin-1-yl)methanone
Similarity: 0.79
[ 1373232-29-1 ]
(R)-1,3-Dimethylpiperazin-2-one hydrochloride
Similarity: 0.78